Is It Too Late to Buy Palantir Stock?

Palantir reported closing 220 customer deals worth more than $1 million each in Q2, totaling over $3.37 billion in contract value. Its AI sovereignty push includes partnerships and bootcamps attended by nearly 200 unique organizations across two events; the article expects this effort to support triple-digit growth in U.S. commercial revenue, but does not provide a forecast period. The commentary is strongly optimistic about Palantir’s growth prospects and shares, citing a gain of more than 1,000% over three years.

Analysis

The bullish case hinges on converting interest in “sovereign AI” into recurring, recognized software revenue—not on bootcamp attendance or headline contract value. The reported $3.37B is contract value, not revenue; deal conversion, duration, renewal economics, and revenue recognition are the missing checks. The author’s expectation of triple-digit U.S. commercial growth is a forecast, not company guidance in the supplied material.

Over 1–3 months, PLTR’s key catalyst is evidence in reported commercial growth and customer expansion that these engagements are becoming production deployments. Over 6–18 months, data control and jurisdictional requirements could support demand, but sovereignty is not uniquely favorable to Palantir: customers may choose local models, in-house systems, or regional integrators to reduce dependence on any external provider. That could limit platform scope or bargaining power. Microsoft, AWS, and Snowflake are plausible alternatives in parts of the stack; the article does not establish that Palantir is difficult to displace.

NVDA may benefit if sovereign deployments expand compute demand; NBIS is a potential infrastructure beneficiary through the cited partnership, but neither relationship establishes material incremental revenue. The contrarian risk is that the narrative is being capitalized faster than deployments can scale. With no valuation or current price data, a fresh outright PLTR long has an unattractive evidence-to-price setup after the reported multi-year run; this is a watch-for-confirmation, not a short thesis.

Key Decisions for Investors

• Do not chase PLTR solely on bootcamp participation or contract-value headlines. Reassess after the next results: look for commercial revenue growth, customer conversions, expansion/renewal evidence, and management guidance; these are the necessary proof points.
• Keep PLTR on an entry alert rather than initiating at an unspecified price. Consider adding only after a pullback that holds through results and is accompanied by confirmed deployment and revenue conversion; avoid inventing a price target without current valuation data.
• Treat NVDA and NBIS as secondary watchlist exposures, not direct proxies for PLTR’s software economics. Verify whether Palantir-related demand appears in their disclosures before attributing incremental earnings to the partnerships.
• Falsify the sovereignty-growth thesis if commercial growth or guidance decelerates without a clear timing explanation, customer additions fail to convert into production deployments, or customers increasingly select local/in-house alternatives.